<!DOCTYPE html>
<html>
<head>
  <title>Vähi signaalirajad</title>
  <meta charset="utf-8">
  <meta name="description" content="Vähi signaalirajad">
  <meta name="author" content="Taavi Päll">
  <meta name="generator" content="slidify" />
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta http-equiv="X-UA-Compatible" content="chrome=1">
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/default.css" media="all" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/phone.css" 
    media="only screen and (max-device-width: 480px)" >
  <link rel="stylesheet" href="libraries/frameworks/io2012/css/slidify.css" >
  <link rel="stylesheet" href="libraries/highlighters/highlight.js/css/tomorrow.css" />
  <base target="_blank"> <!-- This amazingness opens all links in a new tab. -->  <link rel=stylesheet href="./assets/css/ribbons.css"></link>

  
  <!-- Grab CDN jQuery, fall back to local if offline -->
  <script src="http://ajax.aspnetcdn.com/ajax/jQuery/jquery-1.7.min.js"></script>
  <script>window.jQuery || document.write('<script src="libraries/widgets/quiz/js/jquery.js"><\/script>')</script> 
  <script data-main="libraries/frameworks/io2012/js/slides" 
    src="libraries/frameworks/io2012/js/require-1.0.8.min.js">
  </script>
  
  

</head>
<body style="opacity: 0">
  <slides class="layout-widescreen">
    
    <!-- LOGO SLIDE -->
        <slide class="title-slide segue nobackground">
  <hgroup class="auto-fadein">
    <h1>Vähi signaalirajad</h1>
    <h2>Onkobioloogia</h2>
    <p>Taavi Päll<br/>lektor, Tallinna Tehnikaülikool</p>
  </hgroup>
  <article></article>  
</slide>
    

    <!-- SLIDES -->
    <slide class="" id="slide-1" style="background:;">
  <article data-timings="">
    <!-- Limit image width and height -->

<style type="text/css">
img {     
  max-height: 480px;     
  max-width: 600px; 
}
</style>

<style> .title-slide {
  background-image:url(assets/img/TCGA_hotnet.jpg); 
  background-repeat: no-repeat; 
  background-position: 90% 25%; 
  background-size: 45%; 
  background-color: #FFFFFF
  }
  
.title-slide hgroup > h1{
 font-family: 'Oswald', 'Helvetica', sanserif; 
}

.title-slide hgroup > h1, 
.title-slide hgroup > h2 {
  color: #535E43 ;  /* ; #EF5150*/
}
</style>

<!-- Center image on slide -->

<script type="text/javascript" src="http://ajax.aspnetcdn.com/ajax/jQuery/jquery-1.7.min.js"></script>

<script type="text/javascript">
$(function() {     
  $("p:has(img)").addClass('centered'); 
});
</script>

<!-- Italic -->

<style>
em {
  font-style: italic
}
</style>

<!-- Bold -->

<style>
strong {
  font-weight: bold;
}
</style>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-2" style="background:;">
  <hgroup>
    <h2>Recap</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-3" style="background:;">
  <hgroup>
    <h2>Türosiinkinaas retseptorite struktuur</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Inimesel on 58 RTK-d (TK kokku 525 geeni)</li>
<li>RTK tsütoplasmaatiline domään on konserveerunud.</li>
<li>Suur varieeruvus rakuvälises domäänis.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/img/rtk-types.jpg" alt="Drawing" style="width: 500px;"/></p>

<p><footer class="source">Pilt: <a href="http://themedicalbiochemistrypage.org/signal-transduction.php#rtk">themedicalbiochemistrypage.org</a></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-4" style="background:;">
  <hgroup>
    <h2>Mutatsioonid kasvufaktorite retseptorites põhjustavad ligand-sõltumatut aktivatsiooni</h2>
  </hgroup>
  <article data-timings="">
    <p><img src="assets/img/gf-muts.jpg" alt="gfmuts"></p>

<p><footer class="source">The Biology of Cancer (Garland Science 2007)</footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-5" style="background:;">
  <hgroup>
    <h2>Landscape of recurrent kinase fusions in solid tumours</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="http://media.cellsignal.com/www/images/science/diseases/cancer/proteins/alk-ros1/ros-alk-wb-pathway.gif" alt="EML4ALK"></p>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.nature.com/ncomms/2014/140910/ncomms5846/images/ncomms5846-f1.jpg" style="width:480px;"></p>

<p><footer class="source">Pildid: vasem, cellsignal.com; parem, <a href="http://www.nature.com/ncomms/2014/140910/ncomms5846/full/ncomms5846.html">Landscape of recurrent kinase fusions in solid tumours</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-6" style="background:;">
  <hgroup>
    <h2>Kasvufaktorid käivitavad signaalirajad</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-7" style="background:;">
  <hgroup>
    <h2>Rakkude kasv ja jagunemine sõltub kasvufaktoritest</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>10000 inimese endoteelirakku (HUVEC) külvati  96-welli ja kasvatati 20%FBS söötmes </li>
<li>Seejärel rakud sünkroniseeriti rakutsükli G0 faasis, näljutades neid 1%FBS sisaldavas söötmes</li>
<li>5%FBS ja VEGF lisamine vabastas rakud blokist ja indutseeris nad jagunema</li>
<li>Kuidas paneb kasvufaktorite seostumine ja retseptori aktivatsioon käima rakkude jagunemise-kasvu masinavärgi?</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/fig/unnamed-chunk-1-1.png" alt="plot of chunk unnamed-chunk-1"> </p>

<p><footer class="source">Andmed: Anne Pink, Taavi Päll</footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-8" style="background:;">
  <hgroup>
    <h2>Signaaliülekande rada jõuab plasmamembraanist tuuma</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Kasvufaktorite seostumine retseptoritele käivitab rakus kiire ja vahetu vastuse</li>
<li>Kasvufaktorite poolt indutseeritakse minutite jooksul kiirelt teatud geenide transkriptsioon</li>
<li>uute valkude sünteesi ei toimu/ei lähe vaja.</li>
<li>Selliseid kiirelt ekspresseeritavaid geene nimetatakse <strong>varajasteks geenideks (<em>immediate early genes</em>)</strong>.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/img/1471-2199-5-13-2.jpg" style="width:300px;"></p>

<p><footer class="source">Pilt: adapteeritud <a href="http://www.biomedcentral.com/1471-2199/5/13">Expression profiling of serum inducible genes identifies a subset of SRF target genes...</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-9" style="background:;">
  <hgroup>
    <h1>Varajasi geene on kokku kusagil sadakond.</h1>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Geen</th>
<th>Asukoht rakus</th>
<th>Funktsioon</th>
</tr>
</thead><tbody>
<tr>
<td>fos</td>
<td>tuum</td>
<td>AP-1 TF komponent</td>
</tr>
<tr>
<td>junB</td>
<td>tuum</td>
<td>AP-1 TF komponent</td>
</tr>
<tr>
<td>egr-1</td>
<td>tuum</td>
<td>tsinksõrm TF</td>
</tr>
<tr>
<td>nur77</td>
<td>tuum</td>
<td>steroidretseptor</td>
</tr>
<tr>
<td>Srf-1</td>
<td>tuum</td>
<td>TF</td>
</tr>
<tr>
<td>myc</td>
<td>tuum</td>
<td>bHLH TF</td>
</tr>
<tr>
<td>\(\beta\)-aktiin</td>
<td>tsütoplasma</td>
<td>tsütoskelett</td>
</tr>
<tr>
<td>\(\gamma\)-aktiin</td>
<td>tsütoplasma</td>
<td>tsütoskelett</td>
</tr>
<tr>
<td>tropomüosiin</td>
<td>tsütoplasma</td>
<td>tsütoskelett</td>
</tr>
<tr>
<td>fibronektiin</td>
<td>rakuväline</td>
<td>ECM</td>
</tr>
<tr>
<td>glükoositransporter</td>
<td>plasmamembraan</td>
<td>glükoosiimport</td>
</tr>
<tr>
<td>JE</td>
<td>rakuväline</td>
<td>tsütokiin</td>
</tr>
<tr>
<td>KC</td>
<td>rakuväline</td>
<td>tsütokiin</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-10" style="background:;">
  <hgroup>
    <h2>Signaalirajad on rakus ootel ning &#39;<em>ready to fire</em>&#39;</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Seerumvabas söötmes arresteerunud rakkude indutseerimisel seerumiga valgu sünteesi inhibiitori juuresolekul (tsükloheksimiid) toimub varajaste geenide transkriptsioon normaalselt, </li>
<li>viidates, et rakus istuvad seega mingid transkriptsioonifaktorid ja ootavad signaali mobiliseerumiseks.</li>
<li>Lisaks varaste geenide transkriptsiooni indutseerimisele

<ul>
<li>valgusünteesi kiirus suureneb</li>
<li>vahetud muutused raku morfoloogias ja migratsioonis</li>
</ul></li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-11" style="background:;">
  <hgroup>
    <h2>Lisaks muutustele geeniekspressioonis toimuvad muutused ka raku morfoloogias</h2>
  </hgroup>
  <article data-timings="">
    <p><img src="http://d247mjxbujv0d8.cloudfront.net/content/ajpheart/277/5/H2038/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" alt="factin"></p>

<p><footer class="source">Pilt: <a href="http://ajpheart.physiology.org/content/277/5/H2038">VEGF induced rapid formation of actomyosin stress fibers</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-12" style="background:;">
  <hgroup>
    <h2>Varajastele geenidele järgneb sekundaarsete geenide ekspressiooni laine</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="http://www.nature.com/nrm/journal/v12/n2/images/nrm3048-f2.jpg" style="width:480px;"></p>

</div>
<div style='float:right;width:48%;'>
  <ul>
<li>Pidevalt jagunevates rakkudes on paljud varajased geenid negatiivse tagasiside mehhanismide tõttu maha reguleeritud</li>
</ul>

<p><footer class="source">Pilt: <a href="http://www.nature.com/nrm/journal/v12/n2/full/nrm3048.html">Feedback regulation of EGFR signalling: decision making by early and delayed loops</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-13" style="background:;">
  <hgroup>
    <h2>Raku signaaliradade toimimine</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-14" style="background:;">
  <hgroup>
    <h2>Ras valk, osa signaalirajast</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Onkogeenselt aktiveeritud <strong>Ras</strong> (GTPaas) omab rakkudele samasugust transfomeerivat toimet kui <strong>sis</strong> (kasvufaktor) ja <strong>erbB</strong> (retseptor) onkovalgud</li>
<li>Kuidas need onkogeenid omavahel seotud on?</li>
</ul>

<p><img src="assets/img/sis-erb-ras-pthwy.png" alt="sisras"></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-15" style="background:;">
  <hgroup>
    <h2>Ras valgud</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li><strong>Ras valgud toimivad GDP/GTP-sõltuvate lülititena.</strong></li>
<li>Ras-GDP: inaktiivne/Ras-GTP: aktiivne.</li>
<li>Normaalselt on rakkudes Ras seotud GDP-ga ja  mitteaktiivne.</li>
<li>Rakuvälised stiimulid (nt. TGF-\(\alpha\)) põhjustavad transientse Ras-i aktivatsiooni.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.frontiersin.org/files/Articles/57883/fimmu-04-00239-HTML/image_m/fimmu-04-00239-g001.jpg" style="width: 460px;"/></p>

<p><footer class="source">Veel: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354961/">A comprehensive survey of Ras mutations in cancer</a>, <a href="http://www.pnas.org/content/105/17/6260.full">The GAP arginine finger movement into the catalytic site of Ras increases the activation entropy</a> </footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-16" style="background:;">
  <hgroup>
    <h2>Mutantsed Ras valgud on GAP-tundetud</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Ras toimib molekulaarse lülitina, mis aktiveeritakse GTP seostumisel</li>
<li>Ras-i sisse ja välja lülitamist reguleerivad GEF (<em>guanine nucleotide exchange factor</em>) ja GAP (<em>GTPase-activating protein</em>) valgud</li>
<li>GAP valgu seostumine tõstab Ras-i GTP hüdrolüüsi kiirust ~\(10^{5}\) korda</li>
<li>Onkogeenselt aktiveeritud Ras-i mutantidel (nt. G12D, G12V) on väljalülitumine (GTP hüdrolüüs) rikutud</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.rcsb.org/pdb/education_discussion/molecule_of_the_month/images/148-RasProtein_5p21.jpg" alt=""></p>

<p><a href="http://www.rcsb.org/pdb/101/motm.do?momID=148&amp;evtc=Suggest&amp;evta=Moleculeof%20the%20Month&amp;evtl=OtherOptions">April 2012 Molecule of the Month</a></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-17" style="background:;">
  <hgroup>
    <h2>Ras isovormid</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Ras-i on kolm geeni: <strong>K-Ras, H-Ras, N-Ras</strong></li>
<li>K-Ras-il on kaks splaissingu isovormi:K-Ras-4A/B</li>
<li>Ras valkude G-domääni struktuurid on identsed, </li>
<li>kuid C-terminaalsed hüpervariaablid domäänid erinevad.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://ars.els-cdn.com/content/image/1-s2.0-S1535610814000816-gr3.jpg" alt=""></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-18" style="background:;">
  <hgroup>
    <h2>Ras isovormide sagedus vähis</h2>
  </hgroup>
  <article data-timings="">
    <p>Ras mutatsioonid on sagedased. K-Ras on enamasti suveräänne liider (va. N-RAS melanoomis).</p>

<table><thead>
<tr>
<th>Primaarne kude</th>
<th>KRAS (%)</th>
<th>HRAS (%)</th>
<th>NRAS (%)</th>
<th>Kokku (%)</th>
</tr>
</thead><tbody>
<tr>
<td>pankreas</td>
<td>71</td>
<td>0</td>
<td>&lt;1</td>
<td>71</td>
</tr>
<tr>
<td>koolon</td>
<td>35</td>
<td>1</td>
<td>6</td>
<td>42</td>
</tr>
<tr>
<td>peensool</td>
<td>35</td>
<td>0</td>
<td>&lt;1</td>
<td>35</td>
</tr>
<tr>
<td>sapijuha</td>
<td>26</td>
<td>0</td>
<td>2</td>
<td>28</td>
</tr>
<tr>
<td>endomeetrium</td>
<td>17</td>
<td>&lt;1</td>
<td>5</td>
<td>22</td>
</tr>
<tr>
<td>kops</td>
<td>19</td>
<td>&lt;1</td>
<td>1</td>
<td>20</td>
</tr>
<tr>
<td>nahk (melanoom)</td>
<td>1</td>
<td>1</td>
<td>18</td>
<td>20</td>
</tr>
<tr>
<td>emakakael</td>
<td>8</td>
<td>9</td>
<td>2</td>
<td>19</td>
</tr>
<tr>
<td>kusejuha</td>
<td>5</td>
<td>10</td>
<td>1</td>
<td>16</td>
</tr>
</tbody></table>

<p>Lisaks mutatsioonidele on alternatiivselt Ras aktiveeritud ka läbi <strong>neurofibromiini</strong> (Ras-GAP) somaatiliste deletsioonide: 14% glioblastoom, 13-14% melanoom, 8-10% kopsu adenokartsinoom, jne.</p>

<div style='float:left;width:48%;' class='centered'>
  
</div>
<div style='float:right;width:48%;'>
  
</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-19" style="background:;">
  <hgroup>
    <h2>Son of sevenless</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Kasvufaktorite retseptoritest lähtuva signalisatsiooni lahendamine sai alguse <em>Drosophila</em> geneetikast.</li>
<li><em>Drosophila</em> silma ommatiidide arengut reguleeriv geen <strong>sevenless</strong> osutus türosiinkinaas retseptoriks, EGF retseptori homoloogiks.</li>
<li>Edasine geneetiline komplementatsioon identifitseeris signaalirajas &#39;allpool&#39; toimiva geeni <strong><em>son of sevenless</em>, sos</strong>, mis osutus pärmi G valkude guaniin nuleotiidi vahetus faktorile (GEF) sarnaseks valguks.</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://starklab.slu.edu/sev.jpg" style="width: 360px;"/></p>

<p><em>Drosophila</em> sevenless mutandil puudub ommatiididest seitsmes rakk ehk on ainult kuus rakku</p>

<p><footer class="source">Pilt: <a href="http://starklab.slu.edu">Drosophila sevenless mutant</a>  </footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-20" style="background:;">
  <hgroup>
    <h2>Mis on sevenless-sos signaaliraja biokeemiline alus?</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Lisaks identifiseeriti <em>Drosophilas</em> geneetiliselt signaalirajas sevenless ja sos vahel toimivad  adaptervalgud <strong>Shc, Grb2 ja Crk</strong></li>
</ul>

<p><img src="assets/img/signaling_cascade.png"></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-21" style="background:;">
  <hgroup>
    <h2>Kuidas RTK fosforülatsioon tekitab signalisatsiooni?</h2>
  </hgroup>
  <article data-timings="">
    <ol>
<li><p>p-RTK fosforüleerib ja aktiveerib rakus oma substraate</p>

<ul>
<li>aktiveeritud substraadid signaliseerivad</li>
<li>RTK fosforülatsioon sekundaarse tähendusega</li>
</ul></li>
<li><p>p-RTK seob teisi signaalvalke ja muudab nende lokalisatsiooni</p>

<ul>
<li>teiste signaalvalkude sisemine aktiivsus ei muutu</li>
<li>moodustuvad signaliseerimiseks soodsad valgukompleksid</li>
</ul></li>
</ol>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-22" style="background:;">
  <hgroup>
    <h2>Src homoloogsed domäänid vahendavad valkude relokatsiooni</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li><strong>SH1</strong> kinaasne domään (<em>Src homology 1</em>).</li>
<li><strong>SH2</strong> fosfotürosiin peptiidide dokkimiskoht

<ul>
<li>inimese genoomis 121 SH2 domääni 115 valgus</li>
</ul></li>
<li><strong>SH3</strong> proliinirikkaid järjestusi sisaldavate järjestuste dokkimiskoht

<ul>
<li>inimese genoomis ~300 SH3 domääni</li>
</ul></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.nature.com/nrm/journal/v2/n6/images/nrm0601_467a_f3.gif" alt="Drawing" style="width: 460px;"/></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-23" style="background:;">
  <hgroup>
    <h2>Valkude dokkimiskohad</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="http://www.nature.com/nrm/journal/v3/n3/images/nrm759-f1.gif" alt="sh2"></p>

</div>
<div style='float:right;width:48%;'>
  <ul>
<li>SH2/3 pasteeritud väga erinevatesse valgulistesse kontekstidesse

<ul>
<li>puhtalt adaptorvalgud ilma katalüütiliste domäänideta (Shc, Grb2)</li>
<li>katalüütilisi domääne sisaldavad valgud (Src)</li>
</ul></li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-24" style="background:;">
  <hgroup>
    <h2>Olulisemad mitogeense signalisatsiooniga seotud dokkimisdomäänid</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Domään</th>
<th>Ligand</th>
<th>Domääni kandvaid valke</th>
</tr>
</thead><tbody>
<tr>
<td>SH2</td>
<td>fosfotürosiin</td>
<td>Src (kinaas), Grb2 (adapter), Shc (adapter), SHP2 (fosfataas), Cbl (ubikvitiini ligaas)</td>
</tr>
<tr>
<td>PTB</td>
<td>fosfotürosiin</td>
<td>Shc, IRS-1 (insuliini RTK adapter)</td>
</tr>
<tr>
<td>SH3</td>
<td>proliinirikkad järestused</td>
<td>Src, Crk (adapter), Grb2, Cdc25 (CDK fosfataas), Bad (apoptoosi regulator), Raf (ser/thr kinaas), PKC (<em>protein kinase C</em>, ser/thr kinaas)</td>
</tr>
<tr>
<td>Bromo</td>
<td>atsetüleeritud lüsiin</td>
<td>P/CAF (transkriptsiooni kofaktor), kromatiinivalgud</td>
</tr>
<tr>
<td>PH</td>
<td>fosfoinositool</td>
<td>PLC-\(\delta\) (fosfolipaas C), Akt/PKB (ser/thr kinaas)</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-25" style="background:;">
  <hgroup>
    <h2>RTK tsütoplasma domään sisaldab fosfo sidumissaite erinevatele valkudele</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="assets/img/nrm1960-f4.jpg" style="width: 460px;"/></p>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/img/1-s2.0-S0968000412001934-gr3.jpg" alt=""></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-26" style="background:;">
  <hgroup>
    <h2>SH2 grupid vahendavad Ras aktivatsiooni RTK-de poolt</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>türosiinkinaas retseptor-P \(\rightarrow\) SH2-Shc-P \(\rightarrow\) SH2-Grb2-SH3 \(\rightarrow\) proline-rich-Sos \(\rightarrow\) Ras</li>
<li>türosiinkinaas retseptor-P \(\rightarrow\) SH2-Grb2-SH3 \(\rightarrow\) proline-rich-Sos \(\rightarrow\) Ras</li>
</ul>

<p><img src="http://www.nature.com/nrm/journal/v13/n1/images/nrm3255-f1.jpg" alt="trkRas"></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-27" style="background:;">
  <hgroup>
    <h2>Ras aktivatsioonil vabaneb tema &#39;<em>effector loop</em>&#39;</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li><strong>Receptacle for effectors</strong> comprises the so-called &#39;SWITCH REGIONS&#39;, which are three short segments that border the nucleotide-binding site. 

<ul>
<li><strong>P-loop</strong> coordinates nucleotide binding, </li>
<li><strong>switch I and II</strong> regions make up a mobile binding surface that conforms to the nature of a bound nucleotide</li>
</ul></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/img/rasloop.jpg" alt=""></p>

<p><footer class="source">Pilt: doi:10.1038/nrm1229</footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-28" style="background:;">
  <hgroup>
    <h2>Ras aktiveerib kolm põhilist signaalirada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p>Aktiveeritud Ras seotub ja aktiveerib oma effektorvalke:</p>

<ul>
<li><strong>Raf kinaas</strong></li>
<li><strong>Fosfatidüülinositool 3 kinaas, PI3K</strong></li>
<li><strong>RalGDS (Ral GEF)</strong></li>
</ul>

<p><img src="http://ars.els-cdn.com/content/image/1-s2.0-S1535610814000816-gr1.jpg" alt=""></p>

</div>
<div style='float:right;width:48%;'>
  <p><img src="assets/img/RasPI3K.jpg" alt=""></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-29" style="background:;">
  <hgroup>
    <h2>MAPK rada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Ras-Raf-MEK-ERK signaalirada</li>
<li>MAPK rada aktiveeritkse vastusena kasvufaktorite stimulatsioonile, </li>
<li>Paljud MAPK raja substraadid on transkriptioonifacktorid (Ets, Elk-1 SAP-1) aga ka valgusüntees üle Mnk1 kinaasi vahendatud eIF4E aktivatsiooni</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://clincancerres.aacrjournals.org/content/16/13/3329/F1.large.jpg" style="width: 400px;"/></p>

<p><footer class="source"></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-30" style="background:;">
  <hgroup>
    <h2>MAPK raja onkogeenne aktivatsioon</h2>
  </hgroup>
  <article data-timings="">
    <p><img src="http://www.nature.com/onc/journal/v26/n22/images/1210422f1.jpg" alt=""></p>

<p><footer class="source">FROM:Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. P J Roberts and C J Der</footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-31" style="background:;">
  <hgroup>
    <h2>Fosfatidüülinositool 3 kinaas, PI3K rada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <p><img src="assets/img/RasPI3K.jpg" alt=""></p>

<p>Ras - PI3K\(\gamma\) kompleks</p>

</div>
<div style='float:right;width:48%;'>
  <ul>
<li>Ras seostumisel PI3K aktiveeritakse selle katalüütline domään, mis hakkab fosforüleerima plasmamembraanis olevaid fosfatidüül-inositool-4,5-difosfaate (PIP2)</li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-32" style="background:;">
  <hgroup>
    <h2>PI3K fosforüülib PIP2&gt;PIP3</h2>
  </hgroup>
  <article data-timings="">
    <p><img src="http://www.babraham.ac.uk/files/large/f4d5128f14fe6cb" alt=""></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-33" style="background:;">
  <hgroup>
    <h2>Akt kinaas seostub üle oma PH domääni plasmamebraanile</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>PIP3 vahendab PH-domääni sisaldava Akt kinaasi relokatsiooni plasmamembraanile </li>
</ul>

<p><img src="assets/img/plextr.jpg" alt=""></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-34" style="background:;">
  <hgroup>
    <h2>Akt/PKB rada mõjutab rakkude ellujäämist, jagunemist ja kasvu</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Bioloogiline effekt</th>
<th>Akt/PKB substraat</th>
<th>Funktsionaalne tagajärg</th>
</tr>
</thead><tbody>
<tr>
<td>Anti-apoptootiline</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>Bad (pro-apopootline)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td></td>
<td>kaspaas-9 (pro-apopootline)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td></td>
<td>I$\kappa$B kinaas (anti-apopootline)</td>
<td>aktivatsioon</td>
</tr>
<tr>
<td></td>
<td>FOXO1 TF (pro-apopootline)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td></td>
<td>Mdm2 (anti-apopootline)</td>
<td>aktivatsioon</td>
</tr>
<tr>
<td>Rakkude jagunemine</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>GSK-3\(\beta\) (anti-proliferatiivne)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td></td>
<td>FOXO4 TF (anti-proliferatiivne)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td></td>
<td>p21 (anti-proliferatiivne)</td>
<td>inhibitsioon</td>
</tr>
<tr>
<td>Kasv (suurus)</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>Tsc2 (kasvu pidurdav)</td>
<td>inhibitsioon</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-35" style="background:;">
  <hgroup>
    <h1>Genetic Alterations in the PI3K/Akt Pathway in Cancer</h1>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Gene</th>
<th>Type of Alteration</th>
<th>Tumor Lineage</th>
</tr>
</thead><tbody>
<tr>
<td>PTEN</td>
<td>Loss-of-function by somatic mutation</td>
<td>Brain, prostate, endometrium</td>
</tr>
<tr>
<td></td>
<td>Germline mutation (in 80% of Cowden Disease)</td>
<td>Cowden disease: Increased risk for breast, thyroid, genitourinary and endometrial cancer</td>
</tr>
<tr>
<td></td>
<td>Promoter methylation</td>
<td>Melanoma, breast, colon</td>
</tr>
<tr>
<td></td>
<td>Loss of heterozygosity</td>
<td>Prostate, melanoma, thyroid, breast, pancreas, ovary, brain, bladder, endometrium, cervix, head and neck, kidney, lung</td>
</tr>
<tr>
<td>p110α</td>
<td>Gain-of-function by somatic mutation</td>
<td>Colon, breast, brain, ovary</td>
</tr>
<tr>
<td></td>
<td>Amplification</td>
<td>Ovary, gastric, lung, cervix</td>
</tr>
<tr>
<td>p85</td>
<td>Gain-of-function by somatic mutation</td>
<td>Brain, colon, ovary</td>
</tr>
<tr>
<td>AKT1</td>
<td>Gain-of-function by somatic mutation</td>
<td>Breast, colorectal, ovary</td>
</tr>
<tr>
<td>AKT2</td>
<td>Amplification</td>
<td>Ovary, lymphoma, pancreas</td>
</tr>
<tr>
<td></td>
<td>Mutation</td>
<td>Colorectal</td>
</tr>
<tr>
<td>PDK1</td>
<td>Mutation</td>
<td>Colorectal</td>
</tr>
<tr>
<td>TSC1/2</td>
<td>Loss-of-function by mutation (occasionally with concomitant loss of heterozygosity for the wild type allele)</td>
<td>Tuberous sclerosis (hamartomas of the skin, brain and kidney; rare progression to malignancy)</td>
</tr>
<tr>
<td>TSC1</td>
<td>Mutation</td>
<td>Bladder</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-36" style="background:;">
  <hgroup>
    <h2>Ras-RalGDS rada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Ral-GDS(<em>guanine nucleotide dissociation stimulator</em>, GEF) aktiveerib RalA ja RalB GTPaasid</li>
<li>Ral effektorid on RalBP1 mis on Rac/Cdc42 GAP, Sec5 ja Exo84 mis on eksotsüst-kompleksi subühikud, Y-box transkriptsioonifaktor ZONAB</li>
<li> Ral rada reguleerib seega rakkude morfoloogiat, kasvufaktorite retseptorite endotsütoosi, vesikulaarset transporti  ja transkriptsioonifaktoreid</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.nature.com/nrc/journal/v8/n2/images/nrc2296-f1.jpg" alt="ral"></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-37" style="background:;">
  <hgroup>
    <h2>Jak-STAT rada signaliseerib otse tuuma</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Interferooni (IFN), erütropietiini (EPO) ja trombopoietiini (TPO) retseptorid moodustavad mittekovalentse kompleksi Jak türosiin kinaasidega</li>
<li>Ligandi seostumisel rist-aktiveeritakse kinaasid ja fosforüleeritakse retseptorite sabad, millele seostuvad üle SH2 domäänide STAT transkriptsioonifaktorid</li>
<li>Seostunud STAT-ide fosforüleerimisel moodustavad need üle SH2 domäänide dimeeri ja translokeeruvad tuuma</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://blogs.shu.edu/cancer/files/2014/08/figure_06_22.jpg" style="width:460px"></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-38" style="background:;">
  <hgroup>
    <h2>Jak-STAT vähis</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>STAT aktiveerivad muuseas mitmeid rakkude jagunemiseks, ellu jäämiseks ja angiogeneesiks oluliste geenide transkriptsiooni: myc, tsükliinid D2 ja D3 ja anti-apoptootiline Bcl-XL, VEGF </li>
<li>JAK2 V617F mutatsioon multimüeloomides</li>
<li>STAT3 konstitutiivne aktivatsioon mitmetes kasvajates, sh. melanoomis, rinnakasvajates, pea-kaela lamerakulistes kartsinoomides</li>
<li>STAT3 aktivatsioon vahendatud ilmselt üle Src-i</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-39" style="background:;">
  <hgroup>
    <h2>Integriini osalevad kasvufaktorite signalisatsioonis</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Aktiveeritud integriinidele seostunud FAK (<em>focal adhesion kinase</em>) fosforüleerimisel Src poolt tekivad FAK-ile SH2 dokkimiskohad, sh Grb2, Shc, PI3K, PLC-y</li>
<li>FAK seostunud Grb2 seob ka Sos-i on seega võimeline aktiveerima Ras-Raf rada </li>
<li>Integriin vahendatud Ras aktivatsioon võib seletada miks transformatsiooniga kaasneb adhesioon sõltumatu kasv</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.nature.com/ncb/journal/v4/n4/images/ncb0402-e83-f1.gif" alt="ab"></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-40" style="background:;">
  <hgroup>
    <h2>Wnt-\(\beta\)-kateniin rada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>Rada toimib β-kateniini stabiilsuse ja transkriptsioonilise aktiivsuse kontrollina</li>
<li>Ligandi puudumisel toimub Axini kompleks vahendatud \(\beta\)-kateniini lagundamine</li>
<li>Axin kompleks: struktuurvalgud Axin ja tuumor suppressor <em>adenomatous polyposis coli</em> (APC), casein kinase 1 (CK1) ja glycogen synthase kinase 3 (GSK3)</li>
<li>CK1 ja GSK3 fosforüleerivad \(\beta\)-kateniini N-terminusest mistõttu selle tunneb ära \(\beta\)-Trcp E3 ubiquitin ligaasi subühik ja  \(\beta\)-kateniin ubiquitineeritakse ja lagundatakse proteasoomis</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="http://www.nature.com/nrg/journal/v5/n9/images/nrg1427-f1.jpg" style="width:460px"></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-41" style="background:;">
  <hgroup>
    <h2>Wnt raja mutatsioonid vähis</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Affected gene</th>
<th>DNA/mRNA alteration</th>
<th>Functional outcome</th>
<th>Cancer type</th>
</tr>
</thead><tbody>
<tr>
<td>CTNNBl (b-catenin)</td>
<td>Missense/in-frame deletion</td>
<td>Enhanced protein stability</td>
<td>Hepatocellular/Medulloblastoma</td>
</tr>
<tr>
<td>APC (APC)</td>
<td>Truncation</td>
<td>Reduced regulatory activity</td>
<td>Colorectal/gastric</td>
</tr>
<tr>
<td>Axins (Axin I, Axin II)</td>
<td>Truncation/missense</td>
<td>Reduced regulatory activity</td>
<td>Hepatocellular/colorectal</td>
</tr>
<tr>
<td>CREBP(CBP)</td>
<td>Truncation/ missense</td>
<td>Inactive acetyltransferase</td>
<td>Lymphoma/leukemia</td>
</tr>
<tr>
<td>GSK3b</td>
<td>Missplicing, in-frame deletion</td>
<td>Inactive kinase</td>
<td>Leukemia</td>
</tr>
<tr>
<td>LRP5</td>
<td>Missplicing, in-frame deletion</td>
<td>Loss of repression by DKK1</td>
<td>Breast/parathyroid</td>
</tr>
<tr>
<td>TCF7L2 (TCF4)</td>
<td>Missense/deletion/truncation</td>
<td>Loss of repression</td>
<td>Colorectal</td>
</tr>
<tr>
<td>TCF7L2 (TCF4)</td>
<td>Fusion with VT11A gene</td>
<td>Unclear</td>
<td>Colorectal</td>
</tr>
<tr>
<td>FAB123B (WTX)</td>
<td>Truncation/deletion</td>
<td>Loss of function</td>
<td>Wilm’s tumor</td>
</tr>
</tbody></table>

<p><footer class="source">Tabel: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331705/">Wnt Signaling in Cancer</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-42" style="background:;">
  <hgroup>
    <h2>Hedgehog rada</h2>
  </hgroup>
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li>HH ligandid, imetajatel sonic hedgehog (SHH), Indian hedgehog (IHH) ja desert hedgehog (DHH) seostuvad patched 1 (PTCH1) retseptorile</li>
<li>Ligandi seostumine PTCH1-le vabastab smoothened (SMO) transmembraanse valgu inhibitsioonist </li>
<li>SMO signalisatsioon vabastab GLI1, GLI2 ja GLI3 transkriptsioonifaktorid inhibitsioonist tuumorsuppressorvalgu suppressor of fused (SUFU) poolt </li>
<li>GLI1, GLI2 ja GLI3 transporditakse tuuma</li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <p><img src="https://www.dovepress.com/cr_data/article_fulltext/s60000/60262/img/fig1.jpg" style="width:460px"></p>

<p><footer class="source">Pilt: <a href="https://www.dovepress.com/hedgehog-gli-signaling-in-basal-cell-carcinoma-and-other-skin-cancers--peer-reviewed-fulltext-article-RRB">Hedgehog-Gli signaling in basal cell carcinoma and other skin cancers</a></footer></p>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-43" style="background:;">
  <hgroup>
    <h2>Hedgehog rada vähis</h2>
  </hgroup>
  <article data-timings="">
    <ul>
<li>Imetajatel on SUFU Gli aktiivsuse peamine regulator</li>
<li>Pärilikud SUFU mutatsioone on leitud medulloblastoomi, meningioomi patsientidel ja on seotud Gorlini sündroomiga, millega kaasneb kõrge risk saada basaalrakuline kartsinoom </li>
<li>SUFU somaatilisi mutatsioone ja deleteerumist on leitud medulloblastoomides, kondrosarkoomides ja rhabdomüosarkoomides</li>
</ul>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-44" style="background:;">
  <hgroup>
    <h2>HH raja mutatsioonid nahavähkides</h2>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Gene</th>
<th>Mutation type</th>
<th>Tumor type</th>
<th>Percent mutated samples</th>
</tr>
</thead><tbody>
<tr>
<td>Ptch I</td>
<td>Loss-of-function, nonsense</td>
<td>BCC</td>
<td>40-67</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense, splice site</td>
<td>BCC</td>
<td>75</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense</td>
<td>cSCC</td>
<td>17</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense, homozygous deletion</td>
<td>Melanoma</td>
<td>3-5.5</td>
</tr>
<tr>
<td>SMO</td>
<td>Gain-of-function, missense</td>
<td>BCC</td>
<td>9.5-20.6</td>
</tr>
<tr>
<td></td>
<td>Missense</td>
<td>cSCC</td>
<td>7.7</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense, amplification</td>
<td>Melanoma</td>
<td>2.2-8</td>
</tr>
<tr>
<td>SUFU</td>
<td>Missense</td>
<td>BCC</td>
<td>4.7</td>
</tr>
<tr>
<td></td>
<td>Missense</td>
<td>cSCC</td>
<td>2.6</td>
</tr>
<tr>
<td></td>
<td>Missense</td>
<td>Melanoma</td>
<td>0.7-3.3</td>
</tr>
<tr>
<td>Shh</td>
<td>Translocation</td>
<td>BCC</td>
<td>One case</td>
</tr>
<tr>
<td></td>
<td>Missense, frameshift</td>
<td>cSCC</td>
<td>17.9</td>
</tr>
<tr>
<td></td>
<td>Missense, amplification</td>
<td>Melanoma</td>
<td>0-4.7</td>
</tr>
</tbody></table>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-45" style="background:;">
  <hgroup>
    <h1>tabel jätkub</h1>
  </hgroup>
  <article data-timings="">
    <table><thead>
<tr>
<th>Gene</th>
<th>Mutation type</th>
<th>Tumor type</th>
<th>Percent mutated samples</th>
</tr>
</thead><tbody>
<tr>
<td>HHIP</td>
<td>Missense, nonsense, amplification</td>
<td>Melanoma</td>
<td>6.6-9.1</td>
</tr>
<tr>
<td></td>
<td>Missense</td>
<td>cSCC</td>
<td>30.7</td>
</tr>
<tr>
<td>Gli1</td>
<td>Missense, nonsense, amplification</td>
<td>Melanoma</td>
<td>1.1-7.2</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense</td>
<td>cSCC</td>
<td>23</td>
</tr>
<tr>
<td>Gli2</td>
<td>Missense, nonsense, amplification</td>
<td>Melanoma</td>
<td>2.2-12.2</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense</td>
<td>cSCC</td>
<td>25.6</td>
</tr>
<tr>
<td>Gli3</td>
<td>Missense, splice site, amplification</td>
<td>Melanoma</td>
<td>3.3-7.2</td>
</tr>
<tr>
<td></td>
<td>Missense, nonsense</td>
<td>cSCC</td>
<td>23</td>
</tr>
</tbody></table>

<p><footer class="source">Tabel: <a href="https://www.dovepress.com/hedgehog-gli-signaling-in-basal-cell-carcinoma-and-other-skin-cancers--peer-reviewed-fulltext-article-RRB">Hedgehog-Gli signaling in basal cell carcinoma and other skin cancers</a></footer></p>

  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="segue dark nobackground" id="slide-46" style="background:;">
  <hgroup>
    <h2>Lingid teistele loengutele</h2>
  </hgroup>
  <article data-timings="">
    
  </article>
  <!-- Presenter Notes -->
</slide>

<slide class="" id="slide-47" style="background:;">
  <article data-timings="">
    
<div style='float:left;width:48%;' class='centered'>
  <ul>
<li><a href="http://tpall.github.io/sissejuhatus">Sissejuhatav loeng</a></li>
<li><a href="http://tpall.github.io/Vahityybid">Vähitüübid</a></li>
<li><a href="http://tpall.github.io/Onkoviirused">Onkoviirused</a></li>
<li><a href="http://tpall.github.io/Onkogeenid">Onkogeenid</a></li>
<li><a href="http://tpall.github.io/Retseptorid">Retseptorid</a></li>
<li><a href="http://tpall.github.io/Signaalirajad">Signaalirajad</a></li>
<li><a href="http://tpall.github.io/Tuumorsupressorid">Tuumorsupressorgeenid</a></li>
<li><a href="http://tpall.github.io/Rakutsyklikontroll">Rakutsüklikontroll</a></li>
</ul>

</div>
<div style='float:right;width:48%;'>
  <ul>
<li><a href="http://tpall.github.io/p53-ja-apoptoos">p53 ja apoptoos</a></li>
<li><a href="http://tpall.github.io/Immortalisatsioon">Immortalisatsioon</a></li>
<li><a href="http://tpall.github.io/Tumorigenees">Tumorigenees</a></li>
<li><a href="http://tpall.github.io/Genoomiterviklikkus">Genoomiterviklikkus</a></li>
<li><a href="http://tpall.github.io/Mikrokeskkond">Mikrokeskkond</a></li>
<li><a href="http://tpall.github.io/Metastaas">Metastaasid</a></li>
<li><a href="http://tpall.github.io/Immuunsus">Immuunsus</a></li>
<li><a href="http://tpall.github.io/Vahiravim">Vähiravimid</a></li>
</ul>

</div>
  </article>
  <!-- Presenter Notes -->
</slide>

    <slide class="backdrop"></slide>
  </slides>
  <div class="pagination pagination-small" id='io2012-ptoc' style="display:none;">
    <ul>
      <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=1 title='NA'>
         1
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=2 title='Recap'>
         2
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=3 title='Türosiinkinaas retseptorite struktuur'>
         3
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=4 title='Mutatsioonid kasvufaktorite retseptorites põhjustavad ligand-sõltumatut aktivatsiooni'>
         4
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=5 title='Landscape of recurrent kinase fusions in solid tumours'>
         5
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=6 title='Kasvufaktorid käivitavad signaalirajad'>
         6
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=7 title='Rakkude kasv ja jagunemine sõltub kasvufaktoritest'>
         7
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=8 title='Signaaliülekande rada jõuab plasmamembraanist tuuma'>
         8
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=9 title='Varajasi geene on kokku kusagil sadakond.'>
         9
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=10 title='Signaalirajad on rakus ootel ning &#39;<em>ready to fire</em>&#39;'>
         10
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=11 title='Lisaks muutustele geeniekspressioonis toimuvad muutused ka raku morfoloogias'>
         11
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=12 title='Varajastele geenidele järgneb sekundaarsete geenide ekspressiooni laine'>
         12
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=13 title='Raku signaaliradade toimimine'>
         13
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=14 title='Ras valk, osa signaalirajast'>
         14
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=15 title='Ras valgud'>
         15
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=16 title='Mutantsed Ras valgud on GAP-tundetud'>
         16
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=17 title='Ras isovormid'>
         17
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=18 title='Ras isovormide sagedus vähis'>
         18
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=19 title='Son of sevenless'>
         19
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=20 title='Mis on sevenless-sos signaaliraja biokeemiline alus?'>
         20
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=21 title='Kuidas RTK fosforülatsioon tekitab signalisatsiooni?'>
         21
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=22 title='Src homoloogsed domäänid vahendavad valkude relokatsiooni'>
         22
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=23 title='Valkude dokkimiskohad'>
         23
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=24 title='Olulisemad mitogeense signalisatsiooniga seotud dokkimisdomäänid'>
         24
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=25 title='RTK tsütoplasma domään sisaldab fosfo sidumissaite erinevatele valkudele'>
         25
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=26 title='SH2 grupid vahendavad Ras aktivatsiooni RTK-de poolt'>
         26
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=27 title='Ras aktivatsioonil vabaneb tema &#39;<em>effector loop</em>&#39;'>
         27
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=28 title='Ras aktiveerib kolm põhilist signaalirada'>
         28
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=29 title='MAPK rada'>
         29
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=30 title='MAPK raja onkogeenne aktivatsioon'>
         30
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=31 title='Fosfatidüülinositool 3 kinaas, PI3K rada'>
         31
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=32 title='PI3K fosforüülib PIP2&gt;PIP3'>
         32
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=33 title='Akt kinaas seostub üle oma PH domääni plasmamebraanile'>
         33
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=34 title='Akt/PKB rada mõjutab rakkude ellujäämist, jagunemist ja kasvu'>
         34
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=35 title='Genetic Alterations in the PI3K/Akt Pathway in Cancer'>
         35
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=36 title='Ras-RalGDS rada'>
         36
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=37 title='Jak-STAT rada signaliseerib otse tuuma'>
         37
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=38 title='Jak-STAT vähis'>
         38
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=39 title='Integriini osalevad kasvufaktorite signalisatsioonis'>
         39
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=40 title='Wnt-\(\beta\)-kateniin rada'>
         40
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=41 title='Wnt raja mutatsioonid vähis'>
         41
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=42 title='Hedgehog rada'>
         42
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=43 title='Hedgehog rada vähis'>
         43
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=44 title='HH raja mutatsioonid nahavähkides'>
         44
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=45 title='tabel jätkub'>
         45
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=46 title='Lingid teistele loengutele'>
         46
      </a>
    </li>
    <li>
      <a href="#" target="_self" rel='tooltip' 
        data-slide=47 title='NA'>
         47
      </a>
    </li>
  </ul>
  </div>  <!--[if IE]>
    <script 
      src="http://ajax.googleapis.com/ajax/libs/chrome-frame/1/CFInstall.min.js">  
    </script>
    <script>CFInstall.check({mode: 'overlay'});</script>
  <![endif]-->
</body>
  <!-- Load Javascripts for Widgets -->
  
  <!-- MathJax: Fall back to local if CDN offline but local image fonts are not supported (saves >100MB) -->
  <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
      tex2jax: {
        inlineMath: [['$','$'], ['\\(','\\)']],
        processEscapes: true
      }
    });
  </script>
  <script type="text/javascript" src="http://cdn.mathjax.org/mathjax/2.0-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
  <!-- <script src="https://c328740.ssl.cf1.rackcdn.com/mathjax/2.0-latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
  </script> -->
  <script>window.MathJax || document.write('<script type="text/x-mathjax-config">MathJax.Hub.Config({"HTML-CSS":{imageFont:null}});<\/script><script src="libraries/widgets/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"><\/script>')
</script>
<!-- LOAD HIGHLIGHTER JS FILES -->
  <script src="libraries/highlighters/highlight.js/highlight.pack.js"></script>
  <script>hljs.initHighlightingOnLoad();</script>
  <!-- DONE LOADING HIGHLIGHTER JS FILES -->
   
  </html>